Hypertension management in outpatient visits by diabetic patients

Research in Social and Administrative Pharmacy

Volumn 4, Issue 3, 2008, Pages 284-291

  Aparasu, Rajender R ^a   Aparasu, Anuradha ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b East Houston Regional Medical Center   (United States)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors; Angiotensin receptor blockers (ARB); Diabetes; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; AMBULATORY CARE; ARTICLE; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT EDUCATION; RACE;

ADULT; AGED; AMBULATORY CARE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT EDUCATION AS TOPIC;

EID: 51549119491     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2007.07.001     Document Type: Article

References (34)

1. Bakris G.L., Williams M., Dworkin L., et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36 (2000) 646-661
2. Epstein M. Diabetes and hypertension: the bad companions. J Hypertens Suppl 15 (1997) S55-S62
3. Rossing P., Hougaard P., Borch-Johnsen K., et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 313 (1996) 779-784
4. Forrest K.Y., Becker D.J., Kuller L.H., et al. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148 (2000) 159-169
5. Lee E.T., Lee V.S., Lu M., et al. Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study. Diabetes 43 (1994) 572-579
6. Bruno G., Biggeri A., Merletti F., et al. Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study. Diabetes Care 26 (2003) 2353-2358
7. Adler A.I., Stratton I.M., Neil H.A., et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321 (2000) 412-419
8. Orchard T.J., Forrest K.Y., Kuller L.H., et al. Pittsburgh Epidemiology of Diabetes Complications Study. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 24 (2001) 1053-1059
9. Arauz-Pacheco C., Parrott M.A., Raskin P., and American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 26 (2003) S80-S82
10. Chobanian A.V., Bakris G.L., Black H.R., et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
11. Arauz-Pacheco C., Parrott M.A., Raskin P., and American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care 27 (2004) S65-S67
12. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43 (2004) S1-S290
13. Gansevoort R.T., Sluiter W.J., Hemmelder M.H., et al. Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 10 (1995) 1963-1974
14. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355 (2000) 253-259
15. Brenner B.M., Cooper M.E., de Zeeuw D., et al., RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 (2001) 861-869
16. Abuissa H., Jones P.G., Marso S.P., et al. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 46 (2005) 821-826
17. Timpe E.M., Amarshi N., and Reed P.J. Evaluation of angiotensin-converting enzyme inhibitor use in patients with type 2 diabetes in a state managed care plan. Am J Manag Care 10 (2004) 124-129
18. Rosen A.B., Karter A.J., Liu J.Y., et al. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med 19 (2004) 669-675
19. Andros V., Egger A., and Dua U. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes. J Manag Care Pharm 12 (2006) 303-309
20. Winkelmayer W.C., Fischer M.A., Schneeweiss S., et al. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis 46 (2005) 1080-1087
21. Rosen A.B. Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002. J Gen Intern Med 21 (2006) 315-319
22. Grant R.W., Pirraglia P.A., Meigs J.B., et al. Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med 164 (2004) 1134-1139
23. Resnick H.E., Foster G.L., Bardsley J., et al. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 29 (2006) 531-537
24. National Center for Health Statistics. National Ambulatory Medical Care Survey. Hyattsville, MD: United States Department of Health and Human Services, National Center for Health Statistics. Available at: (2004). ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS /doc04.pdf Accessed 29.08.07
25. National Center for Health Statistics. National Hospital Ambulatory Medical Care Survey. Hyattsville, MD: United States Department of Health and Human Services, National Center for Health Statistics. Available at: (2004). ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHAMC S/doc04.pdf Accessed 29.08.07
26. National Center for Health Statistics. National Ambulatory Medical Care Survey. Hyattsville, MD: United States Department of Health and Human Services, National Center for Health Statistics. Available at: (2003). ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS /doc03.pdf Accessed 29.08.07
27. National Center for Health Statistics. National Hospital Ambulatory Medical Care Survey. Hyattsville, MD: United States Department of Health and Human Services, National Center for Health Statistics. Available at: (2004). ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHAMC S/doc03.pdf Accessed 29.08.07
28. US Department of Health and Human Services. Centers for Disease Control and Prevention. Health Care Financing Administration. International Classification of Diseases, 9th Revision, Clinical Modification. 6th edition. 2004.
29. Koch H., and Cambell W. The collection and processing of drug information. National Center for Health Statistics. Vital Health Stat 2 (1982) 1-90
30. In: McEvoy G.K. (Ed). AHFS Drug Information 2006 (2006), American Society of Health-System Pharmacists, Bethesda, MD
31. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual: Research Triangle Park, NC: Research Triangle Institute. Software for Analysis of Correlated Data, Release 8.0; 2002.
32. Douglas J.G., Bakris G.L., Epstein M., et al., for the Hypertension in African Americans Working Group. Management of high blood pressure in African Americans. Consensus statement of the hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163 (2003) 525-541
33. Howard B.V., Lee E.T., Cowan L.D., et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation 99 (1999) 2389-2395
34. Ferdinand K.C. Hypertension in minority populations. J Clin Hypertens 8 (2006) 365-368